ID

26015

Description

Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00427427

Lien

https://clinicaltrials.gov/show/NCT00427427

Mots-clés

Versions (2)
  1. 02/10/2017 02/10/2017 -
  2. 04/10/2017 04/10/2017 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

4 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT00427427

Anglais

Eligibility Breast Cancer NCT00427427

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. confirmed non-metastatic infiltrating carcinoma of the breast.
Description

Infiltrating carcinoma of breast Without Neoplasm Metastasis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0332288
UMLS CUI [1,3]
C0027627
2. her-2 amplified (fish +) determination in 2004 or thereafter.
Description

HER2 gene amplification FISH Positive

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512127
UMLS CUI [1,2]
C0162789
UMLS CUI [1,3]
C1514241
3. ecog performance status 0-2.
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
4. patients 18 years of age or older.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
5. her-2 status is determined by fish test.
Description

HER2/Neu Status FISH test

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512413
UMLS CUI [1,2]
C0162789
6. the following criteria are applicable to the trastuzumab treatment group:
Description

Criteria Trastuzumab Group

Type de données

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C0728747
UMLS CUI [1,3]
C0441833
normal lvef as determined by echo or muga. if baseline lvef > 75%, then lvef shall be repeated to determine if falsely elevated.
Description

LVEF Normal Echocardiography | LVEF Normal MUGA | Baseline LVEF

Type de données

boolean

Alias
UMLS CUI [1,1]
C0428772
UMLS CUI [1,2]
C0205307
UMLS CUI [1,3]
C0013516
UMLS CUI [2,1]
C0428772
UMLS CUI [2,2]
C0205307
UMLS CUI [2,3]
C0521317
UMLS CUI [3,1]
C1442488
UMLS CUI [3,2]
C0428772
adequate bone marrow function as indicated by the following: anc >1500/ml, platelets >/=100,000/ml, hemoglobin >9 g/dl
Description

Bone Marrow function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0518015
adequate renal function,as indicated by serum creatinine </= 1.5 x uln
Description

Renal function | Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
adequate liver function, as indicated by total bilirubin </= 1.5 x uln
Description

Liver function | Serum total bilirubin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
ast and alt < 2 x uln unless related to primary disease.
Description

Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Exception Relationship Primary disease

Type de données

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0439849
UMLS CUI [3,3]
C0277554
if female of childbearing potential, pregnancy test (blood or urine) is negative and she agrees to use effective birth control method for the duration of the study.
Description

Childbearing Potential Serum pregnancy test negative | Childbearing Potential Urine pregnancy test negative | Childbearing Potential Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0430061
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0430057
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
7. signed informed consent has been obtained.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. non-confirmed her-2 positive by fish infiltrating carcinoma of the breast.
Description

Infiltrating carcinoma of breast | FISH HER2/Neu Positive Lacking

Type de données

boolean

Alias
UMLS CUI [1]
C0853879
UMLS CUI [2,1]
C0162789
UMLS CUI [2,2]
C2348909
UMLS CUI [2,3]
C0332268
2. evidence of metastatic disease.
Description

Neoplasm Metastasis

Type de données

boolean

Alias
UMLS CUI [1]
C0027627
3. previous trastuzumab treatment.
Description

Trastuzumab

Type de données

boolean

Alias
UMLS CUI [1]
C0728747
4. concurrent anticancer treatment other than hormonal agents (tamoxifen, aromatase inhibitors) or radiotherapy.
Description

Cancer treatment | Exception Hormonal Agents | Exception Tamoxifen | Exception Aromatase Inhibitors | Therapeutic radiology procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0282559
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0039286
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0593802
UMLS CUI [5]
C1522449
5. patient with history of or active cardiac disease, including cardiomyopathy, congestive heart failure, prior myocardial infarction, or arrhythmia.
Description

Heart Disease | Cardiomyopathy | Congestive heart failure | Myocardial Infarction | Cardiac Arrhythmia

Type de données

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0878544
UMLS CUI [3]
C0018802
UMLS CUI [4]
C0027051
UMLS CUI [5]
C0003811
6. symptomatic intrinsic lung disease resulting in dyspnea at rest.
Description

Lung disease Intrinsic Symptomatic | Resting Dyspnea

Type de données

boolean

Alias
UMLS CUI [1,1]
C0024115
UMLS CUI [1,2]
C0205102
UMLS CUI [1,3]
C0231220
UMLS CUI [2]
C0743330
7. concurrent life-limiting disease with a life expectancy of less than one year.
Description

Disease Life Limiting | Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0376558
UMLS CUI [1,3]
C0439801
UMLS CUI [2]
C0023671
8. pregnancy, nursing women, and fertile women who do not practice birth control.
Description

Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Lacking

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
UMLS CUI [3,3]
C0332268
9. inability to give informed consent.
Description

Informed Consent Unable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT00427427

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Infiltrating carcinoma of breast Without Neoplasm Metastasis
Item
1. confirmed non-metastatic infiltrating carcinoma of the breast.
boolean
C0853879 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
HER2 gene amplification FISH Positive
Item
2. her-2 amplified (fish +) determination in 2004 or thereafter.
boolean
C1512127 (UMLS CUI [1,1])
C0162789 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,3])
ECOG performance status
Item
3. ecog performance status 0-2.
boolean
C1520224 (UMLS CUI [1])
Age
Item
4. patients 18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
HER2/Neu Status FISH test
Item
5. her-2 status is determined by fish test.
boolean
C1512413 (UMLS CUI [1,1])
C0162789 (UMLS CUI [1,2])
Criteria Trastuzumab Group
Item
6. the following criteria are applicable to the trastuzumab treatment group:
boolean
C0243161 (UMLS CUI [1,1])
C0728747 (UMLS CUI [1,2])
C0441833 (UMLS CUI [1,3])
LVEF Normal Echocardiography | LVEF Normal MUGA | Baseline LVEF
Item
normal lvef as determined by echo or muga. if baseline lvef > 75%, then lvef shall be repeated to determine if falsely elevated.
boolean
C0428772 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
C0013516 (UMLS CUI [1,3])
C0428772 (UMLS CUI [2,1])
C0205307 (UMLS CUI [2,2])
C0521317 (UMLS CUI [2,3])
C1442488 (UMLS CUI [3,1])
C0428772 (UMLS CUI [3,2])
Bone Marrow function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement
Item
adequate bone marrow function as indicated by the following: anc >1500/ml, platelets >/=100,000/ml, hemoglobin >9 g/dl
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Renal function | Creatinine measurement, serum
Item
adequate renal function,as indicated by serum creatinine </= 1.5 x uln
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Liver function | Serum total bilirubin measurement
Item
adequate liver function, as indicated by total bilirubin </= 1.5 x uln
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Exception Relationship Primary disease
Item
ast and alt < 2 x uln unless related to primary disease.
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0439849 (UMLS CUI [3,2])
C0277554 (UMLS CUI [3,3])
Childbearing Potential Serum pregnancy test negative | Childbearing Potential Urine pregnancy test negative | Childbearing Potential Contraceptive methods
Item
if female of childbearing potential, pregnancy test (blood or urine) is negative and she agrees to use effective birth control method for the duration of the study.
boolean
C3831118 (UMLS CUI [1,1])
C0430061 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0430057 (UMLS CUI [2,2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
Informed Consent
Item
7. signed informed consent has been obtained.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Infiltrating carcinoma of breast | FISH HER2/Neu Positive Lacking
Item
1. non-confirmed her-2 positive by fish infiltrating carcinoma of the breast.
boolean
C0853879 (UMLS CUI [1])
C0162789 (UMLS CUI [2,1])
C2348909 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
Neoplasm Metastasis
Item
2. evidence of metastatic disease.
boolean
C0027627 (UMLS CUI [1])
Trastuzumab
Item
3. previous trastuzumab treatment.
boolean
C0728747 (UMLS CUI [1])
Cancer treatment | Exception Hormonal Agents | Exception Tamoxifen | Exception Aromatase Inhibitors | Therapeutic radiology procedure
Item
4. concurrent anticancer treatment other than hormonal agents (tamoxifen, aromatase inhibitors) or radiotherapy.
boolean
C0920425 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0282559 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0039286 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0593802 (UMLS CUI [4,2])
C1522449 (UMLS CUI [5])
Heart Disease | Cardiomyopathy | Congestive heart failure | Myocardial Infarction | Cardiac Arrhythmia
Item
5. patient with history of or active cardiac disease, including cardiomyopathy, congestive heart failure, prior myocardial infarction, or arrhythmia.
boolean
C0018799 (UMLS CUI [1])
C0878544 (UMLS CUI [2])
C0018802 (UMLS CUI [3])
C0027051 (UMLS CUI [4])
C0003811 (UMLS CUI [5])
Lung disease Intrinsic Symptomatic | Resting Dyspnea
Item
6. symptomatic intrinsic lung disease resulting in dyspnea at rest.
boolean
C0024115 (UMLS CUI [1,1])
C0205102 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,3])
C0743330 (UMLS CUI [2])
Disease Life Limiting | Life Expectancy
Item
7. concurrent life-limiting disease with a life expectancy of less than one year.
boolean
C0012634 (UMLS CUI [1,1])
C0376558 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0023671 (UMLS CUI [2])
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Lacking
Item
8. pregnancy, nursing women, and fertile women who do not practice birth control.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0332268 (UMLS CUI [3,3])
Informed Consent Unable
Item
9. inability to give informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial